Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer

被引：0
|
作者：
Cao, Hop S. Tran [1 ]
Bouvet, Michael [1 ]
Kaushal, Sharmeela [1 ]
Keleman, Alex [1 ]
Romney, Eric [1 ]
Kim, Ginna [1 ]
Fruehauf, John [1 ]
Imagawa, David K. [1 ]
Hoffman, Robert M. [2 ]
Katz, Matthew H. G. [3 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] AntiCancer Inc, San Diego, CA USA
[3] Univ Calif Irvine, Irvine, CA USA
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2011年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [1] Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
    Cao, Hop S. Tran
    Bouvet, Michael
    Kaushal, Sharmeela
    Keleman, Alex
    Romney, Eric
    Kim, Ginna
    Fruehauf, John
    Imagawa, David K.
    Hoffman, Robert M.
    Katz, Matthew H. G.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) : 2068 - 2078
  • [2] Low Dose Metronomic Gemcitabine has High Antimetastatic Efficacy in an Orthotopic Mouse Model of Pancreatic Cancer
    Cao, H. S. Tran
    Bouvet, M.
    Romney, E.
    Kaushal, S.
    Keleman, A.
    Kim, G.
    Fruehauf, J.
    Imagawa, D. K.
    Hoffman, R. M.
    Katz, M. H.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S65 - S65
  • [3] Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    HPB, 2011, 13 (09) : 597 - 604
  • [4] A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice
    Cortez, Natalia E.
    Lanzi, Cecilia Rodriguez
    Hong, Brian, V
    Xu, Jihao
    Wang, Fangyi
    Chen, Shuai
    Ramsey, Jon J.
    Pontifex, Matthew G.
    Muller, Michael
    Vauzour, David
    Vahmani, Payam
    Hwang, Chang-il
    Matsukuma, Karen
    Mackenzie, Gerardo G.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (09): : 951 - 965
  • [5] Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice
    Beck, AW
    Luster, TA
    Miller, AF
    Holloway, SE
    Conner, CR
    Barnett, CC
    Thorpe, PE
    Fleming, JB
    Brekken, RA
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (10) : 2639 - 2643
  • [6] Glaucarubinone Combined with Gemcitabine Improves Pancreatic Cancer Survival in an Immunocompetent Orthotopic Murine Model
    Yeo, Dannel
    Nhi Huynh
    Beutler, John A.
    Baldwin, Graham S.
    He, Hong
    Nikfarjam, Mehrdad
    JOURNAL OF INVESTIGATIVE SURGERY, 2016, 29 (06) : 366 - 372
  • [7] Combination of metronomic gimatecan and CpG-oligodeoxynucleotides against an orthotopic pancreatic cancer xenograft
    Petrangolini, Giovanna
    Tortoreto, Monica
    Perego, Paola
    Carenini, Nives
    De Cesare, Michelandrea
    Balsari, Andrea
    Zunino, Franco
    Pratesi, Graziella
    CANCER BIOLOGY & THERAPY, 2008, 7 (04) : 596 - 601
  • [8] Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model
    Lee, NC
    Bouvet, M
    Nardin, S
    Jiang, P
    Baranov, E
    Rashidi, B
    Yang, M
    Wang, XE
    Moossa, AR
    Hoffman, RM
    CLINICAL & EXPERIMENTAL METASTASIS, 2001, 18 (05) : 379 - 384
  • [9] Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model
    Natalie C. Lee
    Michael Bouvet
    Stephanie Nardin
    Ping Jiang
    Eugene Baranov
    Babak Rashidi
    Meng Yang
    Xiaoen Wang
    A.R. Moossa
    Robert M. Hoffman
    Clinical & Experimental Metastasis, 2000, 18 : 379 - 384
  • [10] Gemcitabine increases toxicity without altering pancreatic cancer survival
    Goldblatt, MI
    Duelge, JS
    Erickson, EA
    Ritch, PS
    Demeure, MJ
    Wilson, SD
    Pitt, HA
    GASTROENTEROLOGY, 2001, 120 (05) : A483 - A483
12345